Core binding factor (CBF) AML is characterized by the presence of the chromosomal rearrangements t(8;21) and inv(16), causing production of the fusion transcripts RUNX1/RUNX1T1 and CBFB-MYH11, respectively (102). The gene discussed is RUNX1; the disease is acute myeloid leukemia.